HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells

Journal of Clinical Investigation

Volumn 124, Issue 8, 2014, Pages 3431-3442

  Araya, Natsumi ^a   Sato, Tomoo ^a   Ando, Hitoshi ^a   Tomaru, Utano ^b   Yoshida, Mari ^c   Coler Reilly, Ariella ^a   Yagishita, Naoko ^a   Yamauchi, Junji ^a   Hasegawa, Atsuhiko ^d   Kannagi, Mari ^d   Hasegawa, Yasuhiro ^a   Takahashi, Katsunori ^a   Kunitomo, Yasuo ^a   Tanaka, Yuetsu ^e   Nakajima, Toshihiro ^f   Nishioka, Kusuki ^f   Utsunomiya, Atae ^g   Jacobson, Steven ^h   Yamano, Yoshihisa ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e UNIVERSITY OF THE RYUKYUS   (Japan)

^f TOKYO MEDICAL UNIVERSITY   (Japan)

^g Imamura Bun in Hospital   (Japan)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; VIRUS PROTEIN; CCR4 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; SP1 PROTEIN, HUMAN; T-BOX TRANSCRIPTION FACTOR TBX21; TAX PROTEIN; TAX PROTEIN, HUMAN T-LYMPHOTROPHIC VIRUS 1;

ARTICLE; CD4+ T LYMPHOCYTE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; INTERFERON PRODUCTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TROPICAL SPASTIC PARAPARESIS; VIRUS LOAD; ADULT; AGED; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; FEMALE; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; MALE; METABOLISM; MIDDLE AGED; PATHOGENICITY; VIROLOGY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; RECEPTORS, CCR4; SP1 TRANSCRIPTION FACTOR; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; VIRAL LOAD;

EID: 84905472351     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI75250     Document Type: Article

References (61)

1. Murphy KM, Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol. 2010;11(8):674-680.
2. Cosmi L, Maggi L, Santarlasci V, Liotta F, Annunziato F. T helper cells plasticity in inflammation. Cytometry A. 2014;85(1):36-42.
3. + T regulatory cells in human autoimmunity: more than a numbers game. J Immunol. 2011;187(5):2061- 2066.
4. Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA. Plasticity of CD4 (+) FoxP3 (+) T cells. Curr Opin Immunol. 2009;21(3):281-285.
5. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057-1061.
6. Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112(5):1557-1569.
7. Ishida T, Ueda R. Immunopathogenesis of lymphoma: focus on CCR4. Cancer Sci. 2011;102(1):44-50.
8. +CD127lo/-) ex vivo and after in vitro restimulation with malaria antigens. Eur J Immunol. 2010;40(1):47-60.
9. + regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol Reprod. 2010;82(4):698-705.
10. Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol. 2007;8(3):277-284.
11. Bennett CL, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20-21.
12. Gao Y, et al. Molecular mechanisms underlying the regulation and functional plasticity of FOXP3 (+) regulatory T cells. Genes Immun. 2012;13(1):1-13.
13. + regulatory T cells in human autoimmune disease. Nat Med. 2011;17(6):673-675.
14. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8-27.
15. + regulatory T cells in patients with multiple sclerosis. J Exp Med. 2004;199(7):971-979.
16. Kanangat S, et al. Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur J Immunol. 1996;26(1):161-165.
17. Lyon MF, Peters J, Glenister PH, Ball S, Wright E. The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A. 1990;87(7):2433-2437.
18. Clark LB, Appleby MW, Brunkow ME, Wilkinson JE, Ziegler SF, Ramsdell F. Cellular and molecular characterization of the scurfy mouse mutant. J Immunol. 1999;162(5):2546-2554.
19. + T cells in a retrovirus-associated neuroinflammatory disorder. PLoS One. 2009;4(8):e6517.
20. + T cells in patients with HTLV-Iassociated neuroimmunological disease. J Clin Invest. 2005;115(5):1361-1368.
21. Niwa R, et al. Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma. Cancer Res. 2004;64(6):2127-2133.
22. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A. 1984;81(8):2534-2537.
23. Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CR. HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood. 2012;120(17):3488-3490.
24. Zhang L, Zhi H, Liu M, Kuo YL, Giam CZ. Induction of p21 (CIP1/WAF1) expression by human T-lymphotropic virus type 1 Tax requires transcriptional activation and mRNA stabilization. Retrovirology. 2009;6:35.
25. Yu J, et al. Transcriptional control of human T-BET expression: the role of Sp1. Eur J Immunol. 2007;37(9):2549-2561.
26. Araya N, et al. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease. Viruses. 2011;3(9):1532-1548.
27. Ando H, et al. Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. Brain. 2013;136(pt 9):2876-2887.
28. Kohno T, et al. Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci. 2005;96(8):527-533.
29. + T cells in virus-infected individuals. Retrovirology. 2012;9:46.
30. + regulatory T cells. J Immunol. 2010;185(1):183-189.
31. + T cells. J Immunol. 2008;180(2):931-939.
32. Grant C, Oh U, Yao K, Yamano Y, Jacobson S. Dysregulation of TGF-β signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease. Blood. 2008;111(12):5601-5609.
33. Ohsugi T, Kumasaka T. Low CD4/CD8 T-cell ratio associated with inflammatory arthropathy in human T-cell leukemia virus type I Tax transgenic mice. PLoS One. 2011;6(4):e18518.
34. Iwakura Y, et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science. 1991;253(5023):1026-1028.
35. Nakamaru Y, et al. Immunological hyperresponsiveness in HTLV-I LTR-env-pX transgenic rats: a prototype animal model for collagen vascular and HTLV-I-related inflammatory diseases. Pathobiology. 2001;69(1):11-18.
36. Hanon E, et al. High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood. 2001;98(3):721-726.
37. Yamazato Y, Miyazato A, Kawakami K, Yara S, Kaneshima H, Saito A. High expression of p40 (tax) and pro-inflammatory cytokines and chemokines in the lungs of human T-lymphotropic virus type 1-related bronchopulmonary disorders. Chest. 2003;124(6):2283-2292.
38. Nakamura N, et al. Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells. Oncogene. 1999;18(17):2667-2675.
39. Sun SC, Yamaoka S. Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene. 2005;24(39):5952-5964.
40. Lazarevic V, Glimcher LH. T-bet in disease. Nat Immunol. 2011;12(7):597-606.
41. Nishiura Y, Nakamura T, Fukushima N, Moriuchi R, Katamine S, Eguchi K. Increased mRNA expression of Th1-cytokine signaling molecules in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Tohoku J Exp Med. 2004;204(4):289-298.
42. Trejo SR, Fahl WE, Ratner L. The tax protein of human T-cell leukemia virus type 1 mediates the transactivation of the c-sis/platelet-derived growth factor-B promoter through interactions with the zinc finger transcription factors Sp1 and NGFI-A/Egr-1. J Biol Chem. 1997;272(43):27411-27421.
43. Furuya T, et al. Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy. Proc Assoc Am Physicians. 1997;109(3):228-236.
44. Moritoyo T, et al. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol. 1999;5(3):241-248.
45. Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1994;53(1):72-77.
46. Matsuura E, Yamano Y, Jacobson S. Neuroimmunity of HTLV-I Infection. J Neuroimmune Pharmacol. 2010;5(3):310-325.
47. + T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol. 2001;50(6):807-812.
48. Sato T, et al. CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis. PLoS Negl Trop Dis. 2013;7(10):e2479.
49. Yamamoto K, et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemialymphoma and peripheral T-cell lymphoma. J Clin Oncol. 2010;28(9):1591-1598.
50. Ishida T, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012;30(8):837-842.
51. Yamano Y, Sato T. Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Front Microbiol. 2012;3:389.
52. Yamamoto-Taguchi N, et al. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. PLoS Pathog. 2013;9(9):e1003630.
53. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-1987). Br J Haematol. 1991;79(3):428-437.
54. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner W, ed. Human Retrovirology: HTLV. New York, New York, USA: Raven Press; 1990:191-197.
55. Tanaka Y, et al. An antigenic structure of the trans-activator protein encoded by human T-cell leukemia virus type-I (HTLV-I), as defined by a panel of monoclonal antibodies. AIDS Res Hum Retroviruses. 1992;8(2):227-235.
56. Yoshiki T, et al. Models of HTLV-I-induced diseases. Infectious transmission of HTLV-I in inbred rats and HTVL-I env-pX transgenic rats. Leukemia. 1997;11(suppl 3):245-246.
57. Kamihira S, et al. Intra- and inter-laboratory variability in human T-cell leukemia virus type-1 proviral load quantification using real-time polymerase chain reaction assays: a multi-center study. Cancer Sci. 2010;101(11):2361-2367.
58. Bai Y, et al. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector. Gene Ther. 2003;10(17):1446-1457.
59. Nagata K, Ohtani K, Nakamura M, Sugamura K. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J Virol. 1989;63(8):3220-3226.
60. Dull T, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72(11):8463-8471.
61. Shin HJ, Lee JB, Park SH, Chang J, Lee CW. T-bet expression is regulated by EGR1-mediated signaling in activated T cells. Clin Immunol. 2009;131(3):385-394.